Skip to main content

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

HOWL holding history

Werewolf Therapeutics, Inc. in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HOWL overviewAll 13F holders of HOWLFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q2 2022
Holdings of HOWL by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−18,127−100.0%Sold outHolders
Q1 202318,127$47.1K<0.1%+18,127NewHolders
Q4 20220$00.0%−20,200−100.0%Sold outHolders
Q3 202220,200$91.0K<0.1%−1,000−4.7%ReducedHolders
Q2 202221,200$87.0K<0.1%+21,200NewHolders